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Abstract Association reactions of a recombinant CFTR-NBF-2 
polypeptide fused to glutathione S-transferase with guanine 
nucleotides were monitored quantitatively by recording the 
flu~Drescence enhancement of excited trinitrophenol (TNP)- 
labelled GTP after binding to NBF-2. Binding of TNP-GTP to 
the recombinant NBF-2 polypeptide was characterized by a Kd 
value of 3.9 pM. The corrected Kd values for unlabelled guanine 
nucleotides were determined to be 33 ~VI for GTP, 92 [aM for 
GDP and 217 lxM for GMP. TNP-ATP bound to NBF-2 was 
competitively displaced by GTP indicating a common binding 
sitt for both nucleotides. The recombinant NBF-2 did not show 
an intrinsic GTPase activity above a detection limit of 0.007 
min -t.  Our findings provide the first experimental evidence that 
NBF-2 can act as a GTP-binding subunit that would favor the 
release of GDP after GTP hydrolysis. 
Ke,  words: Cystic fibrosis; Cystic fibrosis transmembrane 
co~ductance regulator; Nucleotide binding; Guanosine 
tril~hosphate; G-protein; GTPase activity 
I. Introduction 
~Tystic fibrosis, the most common fatal autosomal recessive 
gel etic disease affecting Caucasian populations [1], results 
frc,~n mutations in the gene coding for the cystic fibrosis trans- 
membrane conductance regulator (CFTR). There is strong 
evilence that CFTR is a membrane chloride channel [2,3] 
which has been predicted to be composed of two motifs of 
six transmembrane spanning segments followed by a nucleo- 
tid,~' binding fold that are separated by a unique regulatory 
(R domain [4]. Both CFTR nucleotide binding folds, NBF-1 
and NBF-2, were identified by the occurrence of Walker A 
and B consensus sequences [5] characterizing NBFs in the 
A~I P-binding cassette family [6]. It could be shown that syn- 
th~ tic peptides as well as recombinant polypeptides, delineated 
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Ab,reviations: CFTR, cystic fibrosis transmembrane conductance 
reg dator; CF, cystic fibrosis; AF, fluorescence enhancement; AFro, 
ma dmal fluorescence enhancement (asymptotic maximum of a fitted 
curve); GST, glutathione S-transferase; GST-NBF-2, glutathione S- 
transferase-CFTR-NBF-2 fusion protein; IPTG, isopropyl-[~-D-thio- 
galactoside; NBF, nucleotide binding fold; TNP-ATP, 2',3'-O-(2,4,6- 
trinitrocyclohexadienylidine) adenosine 5'-triphosphate; TNP-GTP, 
2',2'-O-(2,4,6-trinitrocyclohexadienylidine) gua osine 5'-triphosphate 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. 
PL S0014-5793(96)01  2 1 7-3 
from the amino acid sequence of the two NBFs, are capable 
of binding ATP [7-11]. Furthermore we could demonstrate 
that a NBF-2 polypeptide was able to bind all three adenine 
nucleotides (ATP, ADP and AMP) with high affinity [11]. 
There is now strong evidence that binding of adenine nucleo- 
tides is a crucial step in activation and inhibition of CFTR 
channel gating. Both events appear to be mediated via NBF-2, 
whereas NBF-I  seems to be involved only in ATP-mediated 
channel opening [12,13]. Recently, a similarity in the amino 
acid sequence of CFTR-NBFs and the sequence of heterotri- 
meric G proteins was noted [14]. This observation is of partic- 
ular interest in view of convincing data that show that het- 
erotrimeric G proteins are able to inhibit cAMP activation of 
chloride channels in CF airway epithelial cells [15]. In order to 
investigate whether CFTR itself could play a role in regula- 
tory events as a GTP-binding protein we studied GTP-binding 
activity of a recombinant model of CFTR-NBF-2 showing the 
described adenine nucleotide binding activity. NBF-2 rather 
than NBF-I  was chosen due to its obvious functional parallel 
to a G protein in its behavior as a switch between an opened 
and a closed state of the CFTR channel. In contrast, NBF- I  
appears to be involved only in channel opening by ATP hy- 
drolysis, as discussed by Carson and Welsh [16]. 
In the present study we demonstrate binding of GTP to a 
recombinant NBF-2 polypeptide at the same site and with 
similar affinity as ATP. Furthermore we show significantly 
lower GDP- and GMP-binding activity. This is the first direct 
experimental evidence that NBF-2 is not only capable of bind- 
ing ATP, but also can act as a GTP-binding subunit. 
2. Materials and methods 
2.1. Overexpression a d purification of GST-NBF-2 fusion proteins 
The CFTR sequence from Gly 12°8 to Leu 1399 (numbering according 
to [4]) containing the entire predicted NBF-2 was expressed in fusion 
with GST in E. coli HB101 harboring the expression vector pGEX- 
NBF-2 [l l] using low expression temperatures (25-28°C) and low 
inductor concentrations (0.1 mM IPTG) and purified as described 
previously [11]. For all studies described in this paper only the pri- 
mary soluble fraction of the NBF-2 fusion protein was employed, 
which - in contrast o the insoluble fraction should have achieved 
a properly folded state. In a final step the purified fusion protein was 
extensively dialyzed over 20 h against a 1000-fold excess of 50 mM 
Tris-HCl pH 7.5, which was exchanged 3 times in order to remove 
possible bound guanine nucleotides. Protein chemical characterization 
of the purified recombinant NBF-2 by SDS-PAGE and protein se- 
quencing as well as quantifying the amount of fusion protein was 
done as described [! 1]. 
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2.2. Determination fnucleotide binding characteristics 
The fluorescence enhancement of increasing concentrations of TNP- 
labelled GTP or ATP (Molecular Probes, Eugene, OR) in the presence 
of 1.96 gM GST-NBF-2 or an equivalent amount of GST as control 
in 50 mM Tris-HCl pH 7.5 was recorded at 25°C using a SPEX 
FluoroMax ftuorometer (integration time 8 s). To keep the influence 
of distorting scattered light as low as possible, all titrations were 
carried out with vertically polarized excitation ~, = 408 nm (slit width 
2.35 mm) and horizontally polarized emission Z = 545 nm (slit width 
3.5 mm) [17]. 
The values were corrected for a portion reflecting unspecific binding 
of TNP-labelled nucleotide defined as the amount of fluorescence 
enhancement that was not further de-enhanceable by an excess of 
unlabelled nucleotide. It was calculated as the asymptotic minimum 
of the unlabelled nucleotide titration curves and was assumed to grow 
proportional to the concentration of TNP-labelled nucleotide present 
in the assay. Correction for inner filter effect and fitting of monopha- 
sic binding curves to the corrected fluorescence data were done ac- 
cording to the method described in [11]. 
2.3. Coupled assay for GTPase activity 
A coupled GTP-regenerating enzyme system was employed follow- 
ing the method described by Gonzalo et al. [18]. 0.764 or 1.57 gM 
GST-NBF-2 was incubated together with 1 mM GTP, 90/aM NADH, 
3 mM phosphoenolpyruvate, 8.3/ag/ml lactate dehydrogenase, 25/ag/ 
ml pyruvate kinase (Boehringer Mannheim), 1.2 mM MgC12, 1.5/aM 
EDTA, and 6 mM KC1 in 50 mM Tris-HC1 pH 7.5 at 30°C. AA340/At 
was monitored using an Ultrospec II (LKB Biochrom) spectropho- 
tometer with a stability of + 0.002 A/h. Addition of 130 gM GDP at 
the end of the reaction was used to verify that the assay would have 
indicated nascent GDP. 
3. Results and discussion 
3.1. Quantifying uanine nucleotide binding of  NBF-2 
Guanine nucleotide binding characteristics were obtained 
by measuring the fluorescence nhancement of GTP labelled 
with the extrinsic fluorophore trinitrophenol (TNP) in depend- 
ence on increasing concentrations, which occurs if the fluoro- 
phore is transferred into a less polar environment like a 
protein's nucleotide binding pocket as a consequence of an 
increase in quantum yield [19]. As illustrated in Fig. 1, 
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TNP-GTP was bound with apparently high affinity. It was 
competitively displaced by unlabelled GTP indicating that 
the observed fluorescence nhancement must be a conse- 
quence of GTP and not of TNP binding. No specific enhance- 
ment was recorded using GST instead of the GST-NBF-2 
fusion protein (Fig. 1) or in the presence of 6 M urea (data 
not shown). We calculated a Kd value of 3.9 gM for TNP- 
GTP and a ratio of AF/AFm = 0.82 at the end of titration after 
fitting our data to a binding curve using equations of a bind- 
ing model published by Mullen et al. [20] with the assumption 
that the active binding portion of the recombinant NBF-2 was 
equal to the protein concentration (1.96 gM). In  order to 
validate the latter assumption we had to estimate the magni- 
tude of the active binding fraction of the NBF-2 fusion pro- 
tein because we were not able to determine the amount of 
active binding protein directly by titration since we could 
not further increase the protein concentration in the assay 
for reasons of protein stability in solution of the recombinant 
NBF-2. Therefore we also established the best possible fit to 
the data without any assumption on the active binding protein 
concentration, the Kd value and AFro. The corresponding 
curve fitting to the depicted data was characterized by the 
following parameters: Kd = 3.3 -+ 0.53 gM, active binding pro- 
tein concentration 2.66_+ 0.63 gM and AF/AFm = 0.84 at the 
end of titration. In addition, we tried to fit a monophasic 
binding curve following the equation AF=AFm/(I+KJ 
CTNP-GTP). Here we assumed the concentration of the pro- 
tein-bound TNP-GTP  to be negligible in comparison with 
its total concentration. This would be the case if the concen- 
tration of the active binding fraction of the recombinant 
NBF-2 was at least one magnitude lower than the total pro- 
tein concentration. The results, however, differed significantly 
from the best-fit curve and from the curve assuming an active 
binding NBF-2 concentration of 1.96 gM (calculated values 
for the curve corresponding to the depicted ata: Kd = 5.6 gM; 
AF/AFm =0.77). Since the two curves derived from the non- 
classical binding model of Mullen et al. [20] are nearly iden- 
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Fig. l. Binding characteristics of guanine nucleotides to the NBF-2 fusion protein. Data of fluorescence nhancement (AF) were normalized re- 
ferring to the asymptotic maximum of the fitted curve (AFro). Comparable binding curves were obtained in three independent sets of experi- 
ments. The following Ka values (_+ S.E.M.) were calculated assuming a concentration of functional active protein of 1.96 laM: 3.9 +_ 0.16 /aM 
for TNP-GTP (O), 33+2.5 gM for GTP (O), 92+_5.0 gM for GDP (11), and 217+ 15.4 /aM for GMP (A). As control GST was used, which 
could not cause a specific fluorescence nhancement of TNP-GTP ((3). 
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Fig 2. Competitive displacement of TNP-ATP by GTP. For TNP-ATP a dissociation constant of 22 gM was calculated (+ 1.8 gM S.E.M., 
thr~'e xperiments). The fluorescence enhancement due to binding of TNP-ATP was readily de-enhanceable y an excess of GTP displaying a
cot ected Ka value of 48 gM (+2.2 laM S.E.M.). 
tical, we can conclude that the concentration of the active 
binding portion of the recombinant NBF-2 is of the same 
magnitude as the total protein concentration i the assay. 
W~th a Ka value of 3.9 gM for TNP-GTP the corrected Kd 
vaJae for unlabelled GTP was determined to be 33 gM. 
"he capability of GDP to displace TNP-GTP was about 
three times less compared to GTP and that of GMP was 
one magnitude lower. From these competition experiments 
the following corrected Kd values were calculated: GDP 92 
~tl~l and GMP 217 laM. 
in order to investigate whether the GTP-binding site is 
identical to the ATP-binding site we tried to compete the 
bizding of TNP-ATP with GTP. As illustrated in Fig. 2 
TNP-ATP was bound with a Kd of 22 gM which is identical 
to the Kd value determined in earlier experiments [11]. TNP- 
N IP  could readily be displaced by GTP allowing to calculate 
a t orrected Kd value for GTP of 48/aM. This value is in good 
agreement with the corrected Kd value obtained from the 
competition of TNP-GTP. In previous experiments we have 
be~*n able to determine a similar corrected Kd value for ATP 
(3" gM [11]). These combined observations are consistent 
wih the hypothesis of a common nucleotide binding pocket 
th, t binds GTP and ATP with affinities of the same magni- 
tut,e. 
['he observed GTP-binding affinity of NBF-2 (10 -~ M) is 
lower as compared to known GTPases having Kd values be- 
tw ~'en 10 -11 and 10 7 M [21]. Since we extensively dialyzed 
th, purified NBF-2 protein against a nucleotide-free buffer the 
est mated magnitude of the affinity constant is the correct one 
an t is not the consequence of titrating TNP-GTP against a 
pr,~tein that already has bound GTP or is even saturated with 
G' "P at the beginning of the titration. With regard to the 
m:gnitude of cytoplasmic oncentrations of GTP (> 10 -4 
M according to [21]) GTP saturation of NBF-2 could there- 
fo~ e theoretically depend on changes in the actual concentra- 
titan of GTP in the cytoplasm of the cell. The cytoplasmic 
co ~centrations of GDP are about one magnitude less than 
th,,se of GTP [21] which means that under physiologic on- 
di~ions GDP-binding to NBF-2 would be negligible. Therefore 
in a hypothetical GTPase cycle involving CFTR the release of 
nascent GDP and rebinding of GTP to NBF-2 would be fa- 
vored. 
3.2. Investigation of possible intrinsic GTPase activity of the 
recombinant NBF-2 
For detection of intrinsic GTPase activity of the purified 
recombinant NBF-2 fusion protein a coupled GTP-regenerat- 
ing enzyme system was employed. This assay takes advantage 
of the fact that pyruvate kinase can phosphorylate nascent 
GDP in the presence of phosphoenolpyruvate [18]. This reac- 
tion is followed by oxidation of NADH into NAD + which is 
monitored by photometric analysis. GTP was finally added in 
a concentration f 1 raM, expected to be sufficient to saturate 
NBF-2 according to its Kd. Over a time period of 30 rain and 
with two different NBF-2 concentrations, 0.764/aM and 1.57 
/aM, no significant intrinsic GTPase activity was observed 
above the detection limit of 0.007 min -1 (6.16 pmol/min in 
a 575 tal solution). The assay should have been sensitive n- 
ough to detect slow rates of GTP hydrolysis of about 0.02 
min -1 that are typical for purified GTPases [21] considering 
the evidence given above, that the concentration f the func- 
tional active fraction of the recombinant NBF-2 appears to be 
of the same magnitude as the employed protein concentration. 
Therefore we assume that, if there is any intrinsic hydrolytic 
activity, this activity must be at least one magnitude l ss than 
0.02 min -1. 
Recent crystallographic studies of GTPases like p21 r~S [22], 
Gim [23] and Gta [24] have suggested that the conserved glu- 
tamine in the consensus sequence D-X-[G/A]-G-Q of the G-3 
region [21], just N-terminal to the conserved Walker B se- 
quence, plays a key role in hydrolysis but not in binding of 
GTP [25]. In the corresponding region of CFTR-NBF-2 the 
motif 1347-L-S-H-G-H-1350 fits best to the consensus e- 
quence [16]. In p21 r~ an intrinsic GTPase activity of 0.028 
min 1 has been reported, while the oncogenic mutation of 
the conserved glutamine to histidine (variant Q61H) decreased 
the rate of GTP hydrolysis to 0.0019 min 1 [26]. Transferring 
these findings to the NBF-2 sequence, one would predict no or 
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an only very slow rate of GTP hydrolysis since amino acid 
1350 in NBF-2 is histidine instead of glutamine. This may 
explain the failure to demonstrate GTPase activity of recom- 
binant NBF-2 in our assay. Interestingly, it was recently 
shown that mutation of H1350 to glutamine in CFTR-NBF- 
2 produced channels with a decreased mean burst duration 
[16]. In view of our findings this observation would also be 
consistent with the hypothesis of a higher rate of switching 
into an inactive state as a consequence of GTP hydrolysis [21]. 
3.3. Conclusions 
Our data show that a polypeptide corresponding to the 
second nucleotide binding fold of CFTR can bind GTP at 
the same site and with similar affinity as ATP, suggesting 
that CFTR-NBF-2 is also a GTP-binding subunit. The ob- 
served in vitro affinity for GTP and the reported range of 
cytoplasmic GTP concentrations may suggest hat GTP sat- 
uration of NBF-2 depends on the actual cytoplasmic GTP 
concentration i vivo. Due to the observed affinity for GDP 
together with reported cytoplasmic GDP concentrations our 
model would favor the release of GDP after GTP hydrolysis. 
It is therefore tempting to speculate that hydrolysis of GTP at 
NBF-2 in the presence of some GTPase activating protein or 
allosteric GTP binding in dependence on the local GTP/GDP 
ratio or both might play an important regulating role in the 
timing of channel closing and opening. 
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